TY - JOUR
T1 - Asthma and proinflammatory conditions
T2 - A population-based retrospective matched cohort study
AU - Yun, Hyun Don
AU - Knoebel, Erin
AU - Fenta, Yilma
AU - Gabriel, Sherine E.
AU - Leibson, Cynthia L.
AU - Loftus, Edward V.
AU - Roger, Veronique
AU - Yawn, Barbara P.
AU - Li, Bill
AU - Juhn, Young J.
PY - 2012/10
Y1 - 2012/10
N2 - Objective: To determine the association between asthma and proinflammatory conditions. Participants and Methods: This population-based retrospective matched cohort study enrolled all asthmatic patients among Rochester, Minnesota, residents between January 1, 1964, and December 31, 1983. For each asthmatic patient, 2 age-and sex-matched nonasthmatic individuals were drawn from the same population. The asthmatic and nonasthmatic cohorts were followed forward in the Rochester Epidemiology Project diagnostic index for inflammatory bowel disease (IBD), rheumatoid arthritis (RA), diabetes mellitus (DM), and coronary heart disease (CHD) as outcome events. Data were fitted to Cox proportional hazards models. Results: We identified 2392 asthmatic patients and 4784 nonasthmatic controls. Of the asthmatic patients, 1356 (57%) were male, and mean age at asthma onset was 15.1 years. Incidence rates of IBD, RA, DM, and CHD in nonasthmatic controls were 32.8, 175.9, 132.0, and 389.7 per 100,000 person-years, respectively; those for asthmatic patients were 41.4, 227.9, 282.6, and 563.7 per 100,000 person-years, respectively. Asthma was associated with increased risks of DM (hazard ratio, 2.11; 95% confidence interval, 1.43-3.13; P<.001) and CHD (hazard ratio, 1.47; 95% confidence interval, 1.05-2.06; P=.02) but not with increased risks of IBD or RA. Conclusion: Although asthma is a helper T cell type 2-predominant condition, it may increase the risks of helper T cell type 1-polarized proinflammatory conditions, such as CHD and DM. Physicians who care for asthmatic patients need to address these unrecognized risks in asthmatic patients.
AB - Objective: To determine the association between asthma and proinflammatory conditions. Participants and Methods: This population-based retrospective matched cohort study enrolled all asthmatic patients among Rochester, Minnesota, residents between January 1, 1964, and December 31, 1983. For each asthmatic patient, 2 age-and sex-matched nonasthmatic individuals were drawn from the same population. The asthmatic and nonasthmatic cohorts were followed forward in the Rochester Epidemiology Project diagnostic index for inflammatory bowel disease (IBD), rheumatoid arthritis (RA), diabetes mellitus (DM), and coronary heart disease (CHD) as outcome events. Data were fitted to Cox proportional hazards models. Results: We identified 2392 asthmatic patients and 4784 nonasthmatic controls. Of the asthmatic patients, 1356 (57%) were male, and mean age at asthma onset was 15.1 years. Incidence rates of IBD, RA, DM, and CHD in nonasthmatic controls were 32.8, 175.9, 132.0, and 389.7 per 100,000 person-years, respectively; those for asthmatic patients were 41.4, 227.9, 282.6, and 563.7 per 100,000 person-years, respectively. Asthma was associated with increased risks of DM (hazard ratio, 2.11; 95% confidence interval, 1.43-3.13; P<.001) and CHD (hazard ratio, 1.47; 95% confidence interval, 1.05-2.06; P=.02) but not with increased risks of IBD or RA. Conclusion: Although asthma is a helper T cell type 2-predominant condition, it may increase the risks of helper T cell type 1-polarized proinflammatory conditions, such as CHD and DM. Physicians who care for asthmatic patients need to address these unrecognized risks in asthmatic patients.
UR - http://www.scopus.com/inward/record.url?scp=84871863153&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871863153&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2012.05.020
DO - 10.1016/j.mayocp.2012.05.020
M3 - Article
C2 - 22980164
AN - SCOPUS:84871863153
SN - 0025-6196
VL - 87
SP - 953
EP - 960
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 10
ER -
